Results of the Phase III DASISION trial and the future of CML treatment
The main challenges facing practitioners treating APL
Why do charities need to keep funding research into leukemia and blood cancer in general?
What is the potential of daratumumab in combination therapy for myeloma?
Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine